- Home
- BTO vs TLRY Comparison
BTO vs TLRY Comparison
Compare BTO & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTO
- TLRY
- Stock Information
- Founded
- BTO 1994
- TLRY N/A
- Country
- BTO United States
- TLRY Canada
- Employees
- BTO N/A
- TLRY N/A
- Industry
- BTO Investment Managers
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- BTO Finance
- TLRY Health Care
- Exchange
- BTO Nasdaq
- TLRY Nasdaq
- Market Cap
- BTO 670.7M
- TLRY 624.7M
- IPO Year
- BTO N/A
- TLRY 2018
- Fundamental
- Price
- BTO $35.46
- TLRY $1.03
- Analyst Decision
- BTO
- TLRY Hold
- Analyst Count
- BTO 0
- TLRY 3
- Target Price
- BTO N/A
- TLRY $1.38
- AVG Volume (30 Days)
- BTO 54.2K
- TLRY 78.6M
- Earning Date
- BTO 01-01-0001
- TLRY 10-09-2025
- Dividend Yield
- BTO 9.13%
- TLRY N/A
- EPS Growth
- BTO N/A
- TLRY N/A
- EPS
- BTO N/A
- TLRY N/A
- Revenue
- BTO N/A
- TLRY $821,309,000.00
- Revenue This Year
- BTO N/A
- TLRY $8.95
- Revenue Next Year
- BTO N/A
- TLRY $4.76
- P/E Ratio
- BTO N/A
- TLRY N/A
- Revenue Growth
- BTO N/A
- TLRY 4.10
- 52 Week Low
- BTO $22.95
- TLRY $0.35
- 52 Week High
- BTO $32.81
- TLRY $1.98
- Technical
- Relative Strength Index (RSI)
- BTO 53.00
- TLRY 64.74
- Support Level
- BTO $35.28
- TLRY $0.55
- Resistance Level
- BTO $36.15
- TLRY $1.37
- Average True Range (ATR)
- BTO 0.65
- TLRY 0.12
- MACD
- BTO 0.07
- TLRY 0.05
- Stochastic Oscillator
- BTO 66.82
- TLRY 58.54
About BTO John Hancock Financial Opportunities Fund
John Hancock Financial Opportunities Fund is the United States based closed-end, diversified management investment company. Its investment objective is to provide a high level of total return consisting of long-term capital appreciation and current income. The company invests in banks, capital markets, Insurance, Mortage Real Estate Investment trust, Health Care REITs, Diversified REITs, Office REITs.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. USA exposure consists of CBD products and alcohol.